- Page 1 and 2:
Novel Clinical and Etiopathogenetic
- Page 3:
Thesis submitted to fulfill the req
- Page 7 and 8:
Table of contents o LIST OF ABBREVI
- Page 9:
Publication 8 Low serum vitamin K i
- Page 12:
TE tropoelastin TGF-β transforming
- Page 16 and 17:
the disorder with the xanthomatoses
- Page 18 and 19:
completeness. Non-Mendelian inherit
- Page 20 and 21:
to have an effect on the expression
- Page 22 and 23:
Figure 2 Atomic force microscopic i
- Page 24 and 25:
The metabolic turnover of elastin -
- Page 26 and 27:
McKusick’s categories became appa
- Page 28 and 29:
such as stronger polyanion properti
- Page 30 and 31:
Other negative regulators of uncont
- Page 32 and 33:
called reticular layer of the derm,
- Page 34 and 35:
the epidermis - [82-89] a reticulat
- Page 36 and 37:
Figure 10 Graphic representation of
- Page 38 and 39:
their central sight. It is however
- Page 40 and 41:
The histological structure of the h
- Page 42 and 43:
damage of submucosal arteries have
- Page 44 and 45:
Figure 15 Characteristics of the hu
- Page 46 and 47:
gene [215]. This interaction is sug
- Page 48 and 49:
Le Saux et al. addressed this hypot
- Page 50 and 51:
1.3.7 Animal models An animal model
- Page 52 and 53:
inflammatory drugs should be avoide
- Page 54 and 55:
In our PXE clinic, all patients are
- Page 56 and 57:
energy into an electrical signal, a
- Page 58 and 59:
c/ pattern ERG (PERG) PERG is a ret
- Page 60 and 61:
2.2.2.2 Mutation detection To deter
- Page 62 and 63:
a/ general principles and terminolo
- Page 65 and 66:
Chapter 3 Results o “Une accumula
- Page 67 and 68:
MUTATION IN BRIEF Received 5 May 20
- Page 69 and 70:
Clinical evaluation protocol 55 Nov
- Page 71 and 72:
57 Novel Clinico-molecular Insights
- Page 73 and 74:
59 Novel Clinico-molecular Insights
- Page 75 and 76:
61 Novel Clinico-molecular Insights
- Page 77 and 78:
63 Novel Clinico-molecular Insights
- Page 79:
65 Novel Clinico-molecular Insights
- Page 83 and 84:
ORIGINAL ARTICLE Mutation detection
- Page 85 and 86: ABCC6 mutations in pseudoxanthoma e
- Page 87 and 88: ABCC6 mutations in pseudoxanthoma e
- Page 89 and 90: ABCC6 mutations in pseudoxanthoma e
- Page 91: 3.2 Innovative clinical aspects of
- Page 94 and 95: obtained from all patients and the
- Page 96 and 97: As serum tests for liver and kidney
- Page 99: Publication 4 Pseudoxanthoma elasti
- Page 102 and 103: IOVS, September 2007, Vol. 48, No.
- Page 104 and 105: IOVS, September 2007, Vol. 48, No.
- Page 106 and 107: IOVS, September 2007, Vol. 48, No.
- Page 109: Publication 5 Added value of infrar
- Page 112 and 113: Abstract Purpose: Pseudoxanthoma El
- Page 114 and 115: Patients and Methods Twenty-two pat
- Page 116 and 117: Peau d'orange, which, according to
- Page 118 and 119: Discussion Visualizing the PXE reti
- Page 120 and 121: 3. Vanakker OM, Leroy BP, Coucke PJ
- Page 122 and 123: Figures 108
- Page 125: Publication 6 Heterozygous ABCC6 mu
- Page 128 and 129: Abstract Evidence is emerging that
- Page 130 and 131: Baseline demographic data (age, sex
- Page 132 and 133: Pat. S E X Current age (yrs) Stroke
- Page 134 and 135: providing a basis for future studie
- Page 139 and 140: Pseudoxanthoma Elasticum-Like Pheno
- Page 141 and 142: Table 1. Biochemical analysis resul
- Page 143 and 144: Table 4. Clinical, ultrastructural,
- Page 145: Nucleotide numbers are derived from
- Page 149 and 150: Low serum vitamin K in PXE patients
- Page 151 and 152: Introduction Soft-tissue calcificat
- Page 153 and 154: Immunohistochemistry IHC was perfor
- Page 155 and 156: Serum concentration of vitamin K. M
- Page 157 and 158: found. Unlike PXE-like samples, PXE
- Page 159 and 160: 9. Wajih N, Borras T, Xue W, et al.
- Page 161 and 162: Figures Figure 1 Sandwich ELISA and
- Page 163 and 164: Figure 3 IHC staining for osteocalc
- Page 165: Figure 5 Transmission electron micr
- Page 169 and 170: An atypical case of pseudoxanthoma
- Page 171 and 172: Introduction Pseudoxanthoma elastic
- Page 173 and 174: Biochemical blood analysis, includi
- Page 175 and 176: 11. Tassabehji M, Metcalfe K, Hurst
- Page 177 and 178: ← Figure 2 Ophthalmologic feature
- Page 179 and 180: Chapter 4 Discussion and future per
- Page 181 and 182: Panel A exemplifies the p.R1141X mu
- Page 183 and 184: discussion of sampling error - when
- Page 185 and 186: 4.2.2.1 Anatomical fundus injuries
- Page 187 and 188:
Because also in these individuals n
- Page 189 and 190:
4.2.4 Heterozygous carriers of 1 AB
- Page 191 and 192:
operative blood examination, a defi
- Page 193 and 194:
comparative research project. For t
- Page 195 and 196:
Indeed, in PXE patients no GGCX mut
- Page 197 and 198:
does not present an a priori proble
- Page 199:
not as forthright as one might have
- Page 202 and 203:
diagnostic capacities of limited or
- Page 204 and 205:
eeldvorming, die een duidelijke ver
- Page 206 and 207:
été utilisée jusqu'ici pour l'an
- Page 208 and 209:
25. Neldner, K., Struk B., Pseudoxa
- Page 210 and 211:
68. Vogel, A., U.W. Schnyder, and S
- Page 212 and 213:
115. Pisani, M., et al., [Mottled h
- Page 214 and 215:
162. Connell, J.L., Pseudoxanthoma
- Page 216 and 217:
207. Ilias, A., et al., Loss of ATP
- Page 218 and 219:
249. Lebwohl, M., et al., Diagnosis
- Page 220 and 221:
292. Lommatzsch, A., et al., [Intra
- Page 222 and 223:
342. Miller, R.L., et al., Testicul
- Page 224 and 225:
389. Martin, L., et al., Heterozygo
- Page 227:
Appendix o BALZER, Félix. Recherch
- Page 230 and 231:
October 2007 - present : scientific
- Page 232 and 233:
5/ O.M. Vanakker, L. Martin, D. Ghe
- Page 234 and 235:
Pseudoxanthoma Elasticum. Annual me
- Page 236 and 237:
22/ P. D. Turnpenny, O. M. Vanakker
- Page 238 and 239:
edoeling. Ongetwijfeld ben je tijde
- Page 240:
Virginie: het was telkens een verad